Lipella Pharmaceuticals, Inc. share price logo

Lipella Pharmaceuticals, Inc.

OTC: LIPO

$0.00

as on

Lipella Pharmaceuticals, Inc. Stock Performance

as on September 19, 2026 at 2:45 am IST

  • Day's Low

    Day's High

    $0.04
    $0.06
    downward going graph

    -7900.00%

    Downside

    11900.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.00
    $0.64
    downward going graph

    60.00%

    Downside

    128040.00%

    Upside

    downward going graph

Lipella Pharmaceuticals, Inc. share price movements today

Previous Close
$0.00
Open
$0.06
Volume
217.0
Market Cap
$2.3K
Day's Low - High
$0.04 - $0.06
52 Week Low - High
$0.00 - $0.64

Lipella Pharmaceuticals, Inc. Historical Returns

1 Month Return
+ 66.67 %
3 Month Return
-99.09 %
1 Year Return
-99.92 %
3 Year Return
-100 %
5 Year Return
0 %

Lipella Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Lipella Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3K

EPS (TTM)

-2.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-3.10

PEG Ratio

-0.000008672633784767702

EBITDA

-5.3M

Revenue (TTM)

173.7K

Profit Margin

0.00%

Return On Equity TTM

-140.39%

Lipella Pharmaceuticals, Inc. Stock Valuation

Track how Lipella Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Lipella Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-24.84x)

December 31, 2020

Industry (-3.10x)

December 31, 2024

Today (-0.64x)

December 31, 2024

Highest (-0.64x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.64x

Lipella Pharmaceuticals, Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Lipella Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.3KNANA0.00%0.00%

Stock Returns calculator for Lipella Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Lipella Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lipella Pharmaceuticals, Inc. investment value today

Current value as on today

₹91

Returns

-₹99,909

(-99.91%)

Returns from Lipella Pharmaceuticals, Inc. Stock

-₹99,917 (-99.92%)

Dollar Impact

₹7 (+0.01%)

Analyst Recommendation on Lipella Pharmaceuticals, Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Lipella Pharmaceuticals, Inc.. Average target price of $10

Lipella Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Lipella Pharmaceuticals, Inc..

What analysts predicted

99.99%UPSIDE

Target Price

$10

Current Price

$0.0005

Analyzed by

7 Analysts

Target

$10.00

Lipella Pharmaceuticals, Inc. target price $10, a slight upside of 99.99% compared to current price of $0.0005. According to 7 analysts rating.

Lipella Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
0
0
-
-
-
0
-
-
-
Gross Profit
-1
0
0
0
0
-1
0
0
0
0
Operating Income
-1
-1
0
-1
0
-1
-1
-1
-1
-1
EBITDA
-1
-1
0
-1
0
-1
-1
-1
-1
-1
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
0
-1
0
-1
-1
-1
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-1
0
-1
0
-1
-1
-1
-1
-1
Net Profit Margin
-891.46%
-700.82%
99.40%
99.95%
99.00%
0.00%
-511.71%
0.00%
0.00%
0.00%

Lipella Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Total Revenue
0
0
0
0
0
0
Gross Profit
0
0
-1
-2
-2
-3
Operating Income
0
0
-1
-2
-4
-5
EBITDA
-
0
-1
-2
-4
-5
Interest Expense
0
0
0
0
0
-
Depreciation
0
-
-
-
0
0
Income Before Tax
0
0
-1
-2
-4
-5
Income Tax Expense
-
-
-
-
-
-
Net Income
0
0
-1
-2
-4
-5
Net Profit Margin
1.71%
-1.48%
-461.71%
-1283.43%
-575.87%
-573.65%

Lipella Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-1
-1
0
-1
0
-1
-1
-1
-1
-3,885
Operating Cash Flow
0
0
0
-1
0
0
0
-1
-1
-2,357
Investing Cash Flow
-
0
-
-
-
-
-
-
-
-
Financing Cash Flow
0
-
1
0
-
0
1
3
0
4,210
Change in Cash
0
0
0
-1
0
0
0
2
-1
1,852

Lipella Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Net Income
0
0
-1
-2
-4
-5
Operating Cash Flow
0
0
0
-1
-3
-3
Investing Cash Flow
-
-
0
0
0
-
Financing Cash Flow
0
0
2
5
1
2
Change in Cash
0
0
0
3
-1
-1

Global Institutional Holdings in Lipella Pharmaceuticals, Inc.

Funds
Holdings
Tower Research Capital LLC
0%
Mccormack Advisors International
0%
Virtu Financial LLC
0%
Bank of America Corp
0%

About Lipella Pharmaceuticals, Inc.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
OrganisationLipella Pharmaceuticals, Inc.
Headquarters7800 Susquehanna St., Pittsburgh, PA, United States, 15208
IndustryBiotechnology
CEODr. Jonathan Kaufman M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Lipella Pharmaceuticals, Inc.

Name

Title

Ms. Janet Okonski

Director of Clinical Operations

Katie Johnston

Controller

Dr. Jonathan Kaufman M.B.A., Ph.D.

Co-Founder, Chairman, CEO, President, Secretary & Treasurer

Mr. Douglas Johnston CPA

Chief Financial Officer

Ms. Michele Gruber

Director of Operations

FAQs

What is Lipella Pharmaceuticals, Inc. share price today?

Lipella Pharmaceuticals, Inc. share price today is $0.00 as on at the close of the market. Lipella Pharmaceuticals, Inc. share today touched a day high of $0.06 and a low of $0.04.

What is the 52 week high and 52 week low for Lipella Pharmaceuticals, Inc. share?

Lipella Pharmaceuticals, Inc. share touched a 52 week high of $0.64 on and a 52 week low of $0.00 on . Lipella Pharmaceuticals, Inc. stock price today i.e. is closed at $0.00,which is 99.92% down from its 52 week high and 150.00% up from its 52 week low.

What is Lipella Pharmaceuticals, Inc.'s market capitalisation today?

Lipella Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Lipella Pharmaceuticals, Inc. Stock (LIPO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lipella Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lipella Pharmaceuticals, Inc. Shares that will get you 3000.0000 shares as per Lipella Pharmaceuticals, Inc. share price of $0.00 per share as on September 18, 2026 at 9:15 pm IST.

What is the minimum amount required to buy Lipella Pharmaceuticals, Inc. Stock (LIPO) from India?

Indian investors can start investing in Lipella Pharmaceuticals, Inc. (LIPO) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Lipella Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lipella Pharmaceuticals, Inc. share’s latest price of $0.00 as on September 18, 2026 at 9:15 pm IST, you will get 20000.0000 shares of Lipella Pharmaceuticals, Inc.. Learn more about fractional shares .